Takeda Pharmaceutical Company

TAK

----

Q1 FY2027 Earnings

Financial report interval: 2026.03.30 - 2026.06.30

Overview: Takeda Pharmaceutical Company(TAK) the Revenue is 7.503 B (-2.35%), Beat estimate;the EBIT is 1.239 B (-3.34%), Beat estimate.

Actual

YoY

Estimate

YoY

Vs estimate

YoY

RevenueExceed expectations

7.50B2.35%

7.07B7.98%

+0.43B5.63%

EBITExceed expectations

1.24B3.34%

0.96B25.12%

+0.28B21.78%

Upcoming earnings report - Q2 FY2027

Available dateOct 29, 2026

Estimate Revenue$7.262 B

Estimate EBIT--

Estimate EPS--

Revenue

ActualEstimateUnit: USD

Quarterly

EBIT

ActualEstimateUnit: USD

Quarterly

Net income

ActualEstimateUnit: USD

Quarterly

EPS

ActualEstimateUnit: USD

Quarterly